BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Biosphere Technologies Inc. Release: Alberta Biorefining Process Granted U S and International Patents


10/5/2012 11:28:44 AM

PONOKA, AB, Oct. 5, 2012 /CNW/ - A new Canadian biorefining technology for processing organic waste has been granted a patent by the United States Patent Office for a term effective until 2030. This new thermal hydrolysis and fractionation process, invented by Dr. Erick Schmidt, of Ponoka, Alberta, transforms food waste and animal by-products including meat and bones from carcasses into safe nutrient products for organic fertilizer and biogas production. The innovative technology incorporates centrifugal separation of the hydrolyzed output, creating valuable fractions of fatty acids, amino acids and digestible minerals, and expands the commercial scope of an earlier patent granted in 1999. In addition to this new US patent (# 8,278,081), sister patents for this process have recently been issued by Japan, Australia and South Africa, with additional patents pending in the European Community, Asia and South America.

The technology, named the "BioRefinex process", has been adopted by the 178 member countries of the World Organization for Animal Health (OIE) for the destruction of all infectious microbiological pathogens and TSE agents causing prion diseases such as BSE (Bovine Spongiform Encephalopathy) in cattle and CWD (Chronic Wasting Disease) in elk and deer. The process, which utilizes high pressure and high temperature steam reactors and integrated centrifuges, provides an environmentally superior alternative to incineration and landfilling of disease risk materials such as carcasses, and creates economic value from the nutrient output materials.

The North American patent rights have been assigned by Dr. Schmidt and Biosphere Technologies Inc. to BioRefinex Canada Inc. which is developing an international demonstration and research facility to be located at Lacombe, Alberta. The Lacombe Biorefinery is designed to manufacture organic nutrients for fertilizers and biogas produced by anaerobic digestors for co-generation of "green" electrical power. This biorefining facility will offset greenhouse gases, and has been awarded a $10 million grant from Alberta's Climate Change and Emission Management (CCEMC) Corporation as part of the total project financing. The commercialization of this BioRefinex plant will bring major health and economic benefits to Canadian livestock producers, who now pay a costly penalty for disposal of SRM's (specified risk materials) from cattle over 30 months. This process has been certified by the Canadian Food Inspection Agency (CFIA) for the processing of SRM's as s part of Canada's BSE eradication program.

SOURCE Biosphere Technologies Inc.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES